Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.
Dozens fall ill with norovirus on month-long cruise
Over 50 passengers and 15 crew members reported being ill with norovirus on a month-long cruise on the Coral Princess.